YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report)’s share price shot up 9.2% during trading on Friday . The company traded as high as $19.20 and last traded at $18.70. Approximately 308,695 shares were traded during mid-day trading, an increase of 49% from the average daily volume of 207,254 shares. The stock had previously closed at $17.13.
YieldMax MRNA Option Income Strategy ETF Trading Up 9.2%
The company has a 50-day moving average of $16.54 and a two-hundred day moving average of $17.59.
YieldMax MRNA Option Income Strategy ETF Company Profile
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
Featured Stories
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
